Michael Brotherton

Bridges neuroscience and capital markets: Michael leads a boutique advisory and venture firm focused exclusively on brain health, bringing domain depth and transaction experience to help neuro, mental health, and neurotechnology companies raise capital and execute strategic transactions. dragonfly44+1

Founder / operator role: As Managing Partner (and co‑founder/founder in conference bios) of Dragonfly 44 Capital, he positions the firm as a discreet, rigorous, and aligned advisor offering fundraising, M&A, strategic partnering, and board/leadership strategy support for companies in the neuro sector. dragonfly44+1

Scientific beginnings and research experience: He began his career in endocrinology research and is connected to academic research activity (acknowledged for technical assistance on a paper about thyroid hormone receptor phosphorylation and fasting-related HPT axis suppression). wonderlandconference+1

Public-facing commentator and industry participant: He speaks and appears on industry panels and podcasts about psychedelics, neuropsychiatry, longevity, and human optimization, and is quoted in industry coverage discussing consolidation and regulatory dynamics in ketamine/psychedelics care. apt113+2